Skip to main content

Curis, Inc. (CRIS) Stock Forecast

Data as of May 10, 2026

Healthcare · Current price $0.56 (-2.84%)

Consensus Target
Upside
Analysts
1
Rating
Buy(2.00)

Consensus Price Target Over Time

Analyst Rating Distribution

Last 3 Months

Consensus
Buy
Strong Buy0
Buy1
Hold0
Sell0
Strong Sell0

6-Month Trend

Latest Analyst Forecasts

Price targets issued by Wall Street analysts. Upside calculated against today's price.

No analyst price targets available.

CRIS vs Sector & Market

MetricCRISHealthcare AvgLarge Cap Avg
Analyst Rating2.002.242.41
Analyst Count1819
Target Upside+1708.8%+16.4%
P/E Ratio-10.113.3027.60

Revenue Estimates

PeriodLowAvgHigh#
2026-12-31$7M$8M$8M3
2027-12-31$23M$27M$28M3
2028-12-31$36M$42M$45M4
2029-12-31$102M$119M$127M3
2030-12-31$131M$152M$162M3

EPS Estimates

PeriodLowAvgHigh#
2026-12-31$-1.06$-0.82$-0.413
2027-12-31$-0.57$-0.53$-0.433
2028-12-31$-2.77$-0.59$1.604
2029-12-31$2.23$2.73$2.972
2030-12-31$2.59$3.17$3.452

Frequently Asked Questions

What is the analyst consensus for CRIS?

The consensus among 1 analysts covering Curis, Inc. (CRIS) is Buy with an average price target of N/A.

How many analysts cover CRIS?

1 analysts have issued ratings for Curis, Inc. in the past 12 months.

Is CRIS a buy or sell right now?

Based on 1 analyst ratings, CRIS has a consensus rating of Buy (2.00/5) with a N/A upside to the consensus target of N/A.

What are the earnings estimates for CRIS?

Analysts estimate CRIS will report EPS of $-0.82 for the period ending 2026-12-31, with revenue estimated at $8M.

Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.